Decentralized drug discovery
Xenomine coordinates idle GPU compute, academic wet labs, and hard biological targets. Miners run structure prediction pipelines and earn program tokens — proportional stakes in future licensing revenue.
De novo peptide inhibitors targeting the NDM-1 di-zinc active site to restore meropenem efficacy against carbapenem-resistant gram-negative…
De novo peptide inhibitors targeting the TEAD YBD surface to competitively displace YAP and shut down oncogenic transcription in mesotheliom…
De novo proteins that selectively bind PFOA (C8 perfluorocarboxylate) over endogenous fatty acids — a selective capture medium for PFAS reme…